Showing results (131-140 of 155) with videos related to
Sort By:
Pageof 16
Cancer Science|April 28, 2012
First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: a phase II studyYasushi Tsuji, Taroh Satoh, Akihito Tsuji, et al.Journal of Clinical Medicine|December 10, 2021
Intraperitoneal Chemotherapy as Adjuvant or Perioperative Chemotherapy for Patients with Type 4 Scirrhous Gastric Cancer: PHOENIX-GC2 TrialHironori Ishigami, Yasushi Tsuji, Hisashi Shinohara, et al.The Lancet. Oncology|September 7, 2012
TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trialTakayuki Yoshino, Nobuyuki Mizunuma, Kentaro Yamazaki, et al.BMJ Open|September 1, 2018
Early prediction of lenvatinib treatment efficacy by using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment: a protocol for a non-randomized single-arm multicenter observational studySatoshi Takeuchi, Tohru Shiga, Kenji Hirata, et al.BMC Cancer|October 30, 2021
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancerShun Yamamoto, Kengo Nagashima, Takeshi Kawakami, et al.EJNMMI Research|July 17, 2023
Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised studySatoshi Takeuchi, Kenji Hirata, Keiichi Magota, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 27, 2016
[A Case of Delayed Vascular Injury as a Complication Related to Implanted Central Venous Port Catheter]Tetsuya Sumiyoshi, Tomohiro Kondo, Ryoji Fujii, et al.Cancer Chemotherapy and Pharmacology|September 23, 2020
A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathyMasahito Kotaka, Yoji Saito, Takeshi Kato, et al.Cancer Science|August 24, 2018
Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II studyHiroyuki Ohnuma, Yasushi Sato, Naotaka Hayasaka, et al.Journal of Hepato-Biliary-Pancreatic Sciences|December 2, 2021
Synopsis of a clinical practice guideline for pancreatic ductal adenocarcinoma with peritoneal dissemination in Japan; Japan Peritoneal Malignancy Study GroupSohei Satoi, Naminatsu Takahara, Tsutomu Fujii, et al.Pageof 16